A Study of the Efficacy, Safety, and Quality of Life of Patients With Schizophrenia Receiving Treatment With a Long-acting Injectable Formulation of Risperidone

This study has been completed.

Sponsor:

Information provided by:

Janssen Korea, Ltd., Korea

ClinicalTrials.gov Identifier:

NCT00269919

First received: December 22, 2005

Last updated: June 17, 2011

Last verified: April 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2008
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)